Anoop Enjeti
Calvary Mater Newcastle, Edith Street, Waratah, NSW 2298 Australia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anoop Enjeti as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:29 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05883956 · A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic LeukemiaOtsuka Australia Pharmaceutical Pty Ltd · active not recruiting · Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:29 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.J Clin Oncol · 2019568 citationsRCR 21.6
- 71 citationsRCR 16.3
- 30 citationsRCR 2.6
- A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons.J Psychosoc Oncol · 202026 citationsRCR 1.8
- Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.Nat Commun · 202518 citationsRCR 3.9
- Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.Blood Adv · 20244 citationsRCR 0.3